Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -52.08 | 10.97 |
| PEG Ratio (TTM) | -0.74 | 1.06 |
| P/S Ratio (TTM) | 0.67 | 4.63 |
| P/B Ratio (TTM) | 2.21 | 3.36 |
| P/FCF Ratio (TTM) | 25.02 | 21.49 |
| Price to 5YR AVG Earnings Ratio | -0.61 | 34.71 |
| Price to 5YR AVG FCF Ratio | -2.73 | 16.07 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.17% | 3.30% |
| ROE (TTM) | -5.23% | 9.06% |
| Net Profit Margin (TTM) | -1.25% | -7.58% |
| ROIC 5YR AVG | -155.36% | 6.90% |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 146.80% | 14.95% | 35.36% |
| Revenue | 4.78% | -0.75% | 6.03% |
| Net Income | 127.42% | -3.07% | 18.21% |
| Cash Flow | -1,244.74% | -18.45% | 7.73% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.41 | 2.60 |
| Quick Ratio (TTM) | 2.00 | 1.99 |
| D/E Ratio (TTM) | 0.30 | -0.21 |
| Interest Coverage (TTM) | 0.28 | 13.10 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | N/A | 4.92 |
| LTL to 5YR AVG FCF | -0.47 | 3.00 |
| Shares Outstanding Growth 5YR AVG | 43.12% | 29.31% |